|
FDA Rebuffs Public Citizen’s Request to Ban High-Dose Aricept
The FDA has denied Public Citizen’s appeal for a ban on the 23-mg dose of Eisai’s Alzheimer’s drug Aricept.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives